English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jun 19, 2026

Zebrafish study links altered neuronal genes to hyperarousal states
+ Pharmaceuticals
Patient Daily | Jun 19, 2026

Researchers develop wearable neurorobotic system to aid hand function after neurological injury
+ Pharmaceuticals
Patient Daily | Jun 19, 2026

Psychologist warns DNA testing kits may bring unexpected psychological and privacy risks
+ Pharmaceuticals
Patient Daily | Jun 19, 2026

Researchers develop light-based method to examine chicken eggs non-invasively
+ Pharmaceuticals
Patient Daily | Jun 19, 2026

Experts call for pause or cancellation of FDA’s national priority voucher program
+ Pharmaceuticals
Patient Daily | Jun 19, 2026

NYU Langone performs first HIV-positive-to-HIV-positive lung transplant
+ Pharmaceuticals
Patient Daily | Jun 19, 2026

US investigates German drug pricing policies for impact on American R&D costs
+ Pharmaceuticals
Patient Daily | Jun 19, 2026

Denali sells FDA priority review voucher for $195 million after Avlayah approval

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes